Paris-based startup studio Hexa, known for launching trailblazing B2B software companies like Aircall and Swan, has lifted the curtain on its next wave of innovative ventures. This diverse lineup showcases Hexa’s ability to identify promising ideas and pair them with talented founding teams.
Hexa’s approach involves incubating new concepts within its studio, providing hands-on support across product development, go-to-market strategy, and fundraising. Once the startups secure their initial funding, they transition to become independent companies, with Hexa retaining a 30% stake.
This model has proven successful, with Hexa’s portfolio boasting several unicorns and high-growth firms generating substantial revenues. In the next two years, the studio expects at least five of its pre-2021 startups to reach annual revenues between €100 million and €300 million.
Among Hexa’s latest batch of startups are a weight loss platform leveraging GLP-1 medications, an AI-powered tool for prompt engineering, a skin cancer screening service, and several other B2B solutions targeting legal, compliance, and customer support challenges.
“Hexa continues to demonstrate its knack for identifying and nurturing transformative business ideas,” said Thibaud Elzière, Hexa’s co-founder and CEO. “This new wave of startups showcases our ability to expand into emerging sectors while maintaining our track record of success.”
While Hexa had previously explored a vertical-focused accelerator model, the studio has now centralized its efforts under the Hexa brand. This allows the team to maintain a nimble and adaptive approach, selectively adding new industry verticals as opportunities arise.
As Hexa’s portfolio continues to grow, the startup studio’s reputation as a reliable launchpad for disruptive B2B ventures solidifies. Entrepreneurs and investors alike will be closely watching this latest batch of Hexa-backed startups as they embark on their journeys to shake up their respective markets.